Quest Diagnostics Incorporated (NYSE: DGX), a provider of diagnostic information services, has reaffirmed its outlook for fiscal 2025 and provided cautious first-quarter guidance.
- Quest said it continues to expect full-year 2025 net revenue to be in the range of $10.70 billion to $10.85 billion
- The guidance represents an 8.4% to $9.9% increase in full-year net revenue
- The company reaffirmed its earnings per share guidance for FY25, on a reported basis, in the $8.34-$8.59 range
- Adjusted earnings per share are expected to be between $9.55 and $9.80 in the fiscal year, which is in line with the previous guidance
- The management continues to expect cash provided by operations to be approximately $1.45 billion in FY25, and capital expenditure to be $500 million
- For the first quarter of 2025, the company expects the worse-than-anticipated weather to create a headwind to revenue of around $25 million, and to EPS of about $0.10
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Micron (MU) projects record Q3 revenue, powered by strong HBM sales
Micron’s (NASDAQ: MU) second-quarter report underscores its leadership position in high-bandwidth memory (HBM) chips and AI-driven data center solutions. The expanding portfolio of high-margin products gives the memory chipmaker a
FedEx (FDX): Uncertain demand environment and inflationary pressures dampen outlook
Shares of FedEx Corp. (NYSE: FDX) were down 6% on Friday after the company reported its earnings results for the third quarter of 2025 and lowered its outlook for the
NKE Earnings: Nike reports lower sales for Q3 2025
NIKE, Inc. (NYSE: NKE) has reported a decline in earnings for the third quarter of 2025, hurt by a slowdown in sales across all major markets and operating segments. The
